XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings (Loss) Per Common Share
 9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Earnings (Loss) Per Common Share
Earnings (Loss) Per Common Share
The following table sets forth the computations of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2017 and 2016 (in thousands, except per share data):
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 Basic earnings (loss) per common share:

 
2017
 
2016
 
2017
 
2016
Numerator:
 
 
 
 
 
 
 
 
Net earnings (loss) from continuing operations
 
$
1,077

 
$
2,150

 
$
(1,096
)
 
$
2,052

Net (loss) earnings from discontinued operations
 
$
(344
)
 
$
133

 
$
(1,029
)
 
$
(914
)
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
22,498

 
21,847

 
22,225

 
22,084

Effect of dilutive securities from stock-based compensation plans
 
263

 
27

 
—

 
30

Weighted-average diluted common shares outstanding
 
22,761

 
21,874

 
22,225

 
22,114

 
 
 
 
 
 
 
 
 
Basic earnings (loss) per common share from continuing operations
 
$
0.05

 
$
0.10

 
$
(0.05
)
 
$
0.09

Basic earnings (loss) per common share from discontinued operations
 
(0.02
)
 
0.01

 
(0.05
)
 
(0.04
)
Total basic earnings (loss) per common share
 
$
0.03

 
$
0.11

 
$
(0.10
)
 
$
0.05

 
 
 
 
 
 
 
 
 
Diluted earnings (loss) per common share from continuing operations
 
$
0.05

 
$
0.10

 
$
(0.05
)
 
$
0.09

Diluted earnings (loss) per common share from discontinued operations
 
(0.02
)
 
0.01

 
(0.05
)
 
(0.04
)
Total diluted earnings (loss) per common share
 
$
0.03

 
$
0.11

 
$
(0.10
)
 
$
0.05



For the periods presented that generated a net loss, basic and diluted net loss per share are the same, as any additional common stock equivalents would be anti-dilutive. For the three months ended September 30, 2017, there were 1.9 million of anti-dilutive stock options and 1.9 million of anti-dilutive shares underlying restricted stock units that were excluded from the calculation of weighted average diluted common shares outstanding. For the three months ended September 30, 2016, there were 2.8 million of anti-dilutive stock options and 2.7 million of anti-dilutive shares underlying restricted stock units that were excluded from the calculation of weighted average diluted shares outstanding. For the nine-month period ended September 30, 2016, there were 2.8 million of anti-dilutive shares underlying stock options and 2.0 million of anti-dilutive shares underlying restricted stock units that were excluded from the calculation of weighted average diluted common shares outstanding.

We repurchased no shares of our common stock under our stock repurchase program during the three and nine months ended September 30, 2017. During the three and nine months ended September 30, 2016, we repurchased less than 0.1 million shares and 0.9 million shares of our common stock for $0.1 million and $3.8 million, respectively, under our stock repurchase program.

Pursuant to exercises of outstanding stock options, we issued 16,000 shares of our common stock having a value of approximately $0.1 million in the three months ended September 30, 2017 and 183,460 shares of our common stock having a value of approximately $0.9 million in the nine months ended September 30, 2017. In connection with stock option exercises, we issued no shares of our common stock in the three months ended September 30, 2016, and 46,896 shares of our common stock having a value of less than $0.1 million in the nine months ended September 30, 2016.